ECO Animal Health Group
plc
("ECO" or
the "Company")
ECO Animal Health General
meeting resolution passed
ECO Animal Health Group plc (AIM:
EAH), a rapidly growing global animal
health company with a portfolio of marketed veterinary products and
a maturing proprietary R&D pipeline, announces that
at its General Meeting held earlier today ("GM")
the special resolution proposed to the meeting to allow the Company
to make market purchases of its own shares was duly
passed.
Proxy votes received in relation to
the resolution were as follows:
|
Resolution
|
For
|
%
|
Discretionary
|
%
|
Against
|
%
|
Withheld
|
|
01
|
40,553,465
|
97.6
|
Nil
|
0
|
1,011,642
|
2.4
|
Nil
|
As previously announced the Company
disposed of certain surplus freehold properties and received net
proceeds of £1,058,454. The board stated that it intends to use the
majority of these proceeds to advance the growth aspirations of
ECO. The Board also announced that it intends to use some of the
proceeds to purchase ordinary shares of the Company ("Ordinary
Shares") in the market to cover possible future vesting of employee
share-based incentives. The authority conferred by this
resolution will be used to purchase a maximum of 270,000 Ordinary
Shares in the market which is expected to cost no more than
£300,000.
In addition, in the remaining weeks
before the close of the financial year ending 31 March 2024, the
Company intends to issue a trading update.
David Hallas, CEO of ECO, commented: "We are pleased to have received approval from our
shareholders enabling us to pursue this one-off share purchase. The
Board agreed that now is the optimal time to use proceeds from our
recent property disposals to purchase shares that will be used to
satisfy share based staff incentives."
-Ends-
For
further information please contact:
|
ECO
Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
|
020 8447 8899
|
|
Singer Capital Markets (Nominated Adviser & Joint
Broker)
Phil Davies
Sam Butcher
|
020 7496 3000
|
|
Investec (Joint Broker)
Gary Clarence
Lydia Zychowska
|
020 7597 5970
|
|
Equity Development
Hannah Crowe
Matt Evans
|
020 7065 2692
|
|
ICR
Consilium (Financial PR)
Mary-Jane Elliott
Jessica Hodgson
|
020 3709 5700
ecoanimalhealth@consilium-comms.com
|
|
|
About ECO Animal Health
ECO Animal Health is a world leader
in animal health, developing and marketing branded veterinary
pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary
R&D pipeline.
Headquartered in the UK, with global
offices including R&D and manufacturing, we have marketing
authorisations in over 70 countries and employ over 200 people
worldwide.
Our lead product, Aivlosin® is a
proprietary, patented medication which is effective against both
respiratory and intestinal diseases in pigs and
poultry.
Click here for more
information: https://ecoanimalhealth.com
